Impact of local treatment on survival outcomes in patients with metastatic lung cancer with oligoprogression undergoing immunotherapy. Swiss Medical Weekly, [S. l.], v. 156, n. 4, p. 4790, 2026. DOI: 10.57187/4790. Disponível em: https://smw.ch/index.php/smw/article/view/4790. Acesso em: 29 apr. 2026.